Hiroko Ishida
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 10
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Kazuki Hoshino (9 shared papers)Olga Lomovskaya (3 shared papers)Mark S. Warren (3 shared papers)Suzanne Chamberland (2 shared papers)Roger Léger (2 shared papers)Angela Y. Lee (1 shared paper)Jorge L. Galazzo (1 shared paper)May Lee (1 shared paper)
In The Last Decade
Hiroko Ishida
26 papers receiving 1.8k citations
Hiroko Ishida's Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Medicine 1.2k
- Applied Microbiology and Biotechnology 37
- Oncology 268
- Endocrinology 30
- Pharmacology 81
Countries citing papers authored by Hiroko Ishida
This map shows the geographic impact of Hiroko Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Ishida more than expected).
Fields of papers citing papers by Hiroko Ishida
This network shows the impact of papers produced by Hiroko Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Ishida. The network helps show where Hiroko Ishida may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Ishida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy Hit paper breakdown → | 2001 | 793 |
| 2 | 2000 | 214 | |
| 3 | 1999 | 193 | |
| 4 | 1997 | 145 | |
| 5 | 1998 | 122 | |
| 6 | 2003 | 76 | |
| 7 | 2021 | 76 | |
| 8 | 1996 | 61 | |
| 9 | 2003 | 59 | |
| 10 | 2003 | 53 | |
| 11 | 2004 | 47 | |
| 12 | 1992 | 31 | |
| 13 | 1995 | 27 | |
| 14 | 1995 | 27 | |
| 15 | 1997 | 24 | |
| 16 | 1985 | 23 | |
| 17 | Purification and characterization of 7α-hydroxy-4-cholesten-3-one 12α-hydroxylase | 1992 | 19 |
| 18 | 1993 | 18 | |
| 19 | 1996 | 13 | |
| 20 | 2011 | 10 |
About Hiroko Ishida
Hiroko Ishida is a scholar working on Molecular Medicine, Pharmacology, Pharmacology, Surgery and Molecular Biology, having authored 28 papers that have together received 2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Steroid Chemistry and Biochemistry (4 papers), Cholesterol and Lipid Metabolism (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper) and Hearing, Cochlea, Tinnitus, Genetics (1 paper). The work is most often cited by research in Molecular Medicine (1.2k citations), Applied Microbiology and Biotechnology (37 citations), Oncology (268 citations), Endocrinology (30 citations) and Pharmacology (81 citations). Hiroko Ishida has collaborated with scholars based in Japan, Sweden and China. Frequent co-authors include Kazuki Hoshino, Olga Lomovskaya, Mark S. Warren, Suzanne Chamberland, Roger Léger, Angela Y. Lee, Jorge L. Galazzo, May Lee, Scott J. Hecker and Richard M. Fronko. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Journal of Cardiac Failure and Steroids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.